The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Chronic microglial activation and progressive dopaminergic neurotoxicity
Abstract
PD (Parkinson's disease) is characterized by the selective and progressive loss of DA neurons (dopaminergic neurons) in the substantia nigra. Inflammation and activation of microglia, the resident innate immune cell in the brain, have been strongly linked to neurodegenerative diseases, such as PD. Microglia can respond to immunological stimuli and neuronal death to produce a host of toxic factors, including cytokines and ROS (reactive oxygen species). Microglia can also become persistently activated after a single stimulus and maintain the elevated production of both cytokines and ROS, long after the instigating stimulus is gone. Current reports suggest that this chronic microglial activation may be fuelled by either dying/damaged neurons or autocrine and paracrine signals from local glial cells, such as cytokines. Here, we review proposed mechanisms responsible for chronic neuroinflammation and explain the interconnected relationship between deleterious microglial activation, DA neuron damage and neurodegenerative disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Self-citationMcGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144
Self-citationMicroglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Self-citationZhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265
Self-citationWu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Streit, W. J., Walter, S. A., & Pennell, N. A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00069-0 · Cited by 1,096
Phagocytes and oxidative stress
Babior, B. M. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00481-2 · Cited by 1,061
Systemic infections and inflammation affect chronic neurodegeneration
Perry, V. H., Cunningham, C., & Holmes, C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2015 · Cited by 1,027
Godbout, J. P., Chen, J., Abraham, J., Richwine, A. F., Berg, B. M., Kelley, K. W., & Johnson, R. W. (2005) · The FASEB Journal · doi:10.1096/fj.05-3776fje · Cited by 813
Gao, H., Jiang, J., Wilson, B., Zhang, W., Hong, J., & Liu, B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00928.x · Cited by 687
Self-citationWu, D.-C., Teismann, P., Tieu, K., Vila, M., Jackson-Lewis, V., Ischiropoulos, H., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0937239100 · Cited by 633
Qin, L., Liu, Y., Wang, T., Wei, S.-J., Block, M. L., Wilson, B., Liu, B., & Hong, J.-S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307657200 · Cited by 574
Self-citationNeuropathologic changes in Alzheimer's disease.
Wenk, G. L. (2003) · PubMed · Cited by 554
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease
McNaught, K. S. P., Perl, D. P., Brownell, A., & Olanow, C. W. (2004) · Annals of Neurology · doi:10.1002/ana.20186 · Cited by 548
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H.-M., Hong, J.-S., Zhang, W., & Liu, B. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00782.2002 · Cited by 439
Self-citationMcGeer, P. L., Schwab, C., Parent, A., & Doudet, D. (2003) · Annals of Neurology · doi:10.1002/ana.10728 · Cited by 400
Block, M. L., Wu, X., Pei, Z., Li, G., Wang, T., Qin, L., Wilson, B., Yang, J., Hong, J. S., & Veronesi, B. (2004) · The FASEB Journal · doi:10.1096/fj.04-1945fje · Cited by 376
Self-citationSriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., & O'Callaghan, J. P. (2002) · The FASEB Journal · doi:10.1096/fj.02-0216fje · Cited by 362
Critical Role for Microglial NADPH Oxidase in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H.-M., Liu, B., & Hong, J.-S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06181.2003 · Cited by 337
Self-citationGao, H.-M., Liu, B., Zhang, W., & Hong, J.-S. (2003) · The FASEB Journal · doi:10.1096/fj.03-0109fje · Cited by 306
Self-citationActivation of NADPH Oxidase in Alzheimer’s Disease Brains
Shimohama, S., Tanino, H., Kawakami, N., Okamura, N., Kodama, H., Yamaguchi, T., Hayakawa, T., Nunomura, A., Chiba, S., Perry, G., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2897 · Cited by 292
Qin, L., Liu, Y., Cooper, C., Liu, B., Wilson, B., & Hong, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01210.x · Cited by 292
Self-citationLiu, B., Gao, H.-M., & Hong, J.-S. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6361 · Cited by 285
Self-citationChoi, D.-K., Pennathur, S., Perier, C., Tieu, K., Teismann, P., Wu, D.-C., Jackson-Lewis, V., Vila, M., Vonsattel, J.-P., Heinecke, J. W., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0970-05.2005 · Cited by 282
Kim, Y. S., Kim, S. S., Cho, J. J., Choi, D. H., Hwang, O., Shin, D. H., Chun, H. S., Beal, M. F., & Joh, T. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4346-04.2005 · Cited by 258
Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys
Miklossy, J., Doudet, D. D., Schwab, C., Yu, S., McGeer, E. G., & McGeer, P. L. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.10.034 · Cited by 255
Gao, H.-M., Hong, J.-S., Zhang, W., & Liu, B. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01228.2003 · Cited by 251
Self-citationSriram, K., Miller, D. B., & O'Callaghan, J. P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03566.x · Cited by 242
Ling, Z., Gayle, D. A., Ma, S. Y., Lipton, J. W., Tong, C. W., Hong, J., & Carvey, P. M. (2002) · Movement Disorders · doi:10.1002/mds.10078 · Cited by 241
Self-citationVijitruth, R., Liu, M., Choi, D.-Y., Nguyen, X. V., Hunter, R. L., & Bing, G. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-6 · Cited by 236
Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., & O'Callaghan, J. P. (2006) · The FASEB Journal · doi:10.1096/fj.05-5106com · Cited by 222
CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease
Elbaz, A., Levecque, C., Clavel, J., Vidal, J., Richard, F., Amouyel, P., Alpérovitch, A., Chartier‐Harlin, M., & Tzourio, C. (2004) · Annals of Neurology · doi:10.1002/ana.20051 · Cited by 213
Pathology of Parkinson's Disease
(2006) · Understanding Parkinson's Disease · doi:10.5040/9798216029700.0007 · Cited by 206
Zhang, W., Wang, T., Qin, L., Gao, H., Wilson, B., Ali, S. F., Zhang, W., Hong, J., & Liu, B. (2004) · The FASEB Journal · doi:10.1096/fj.03-0983fje · Cited by 204
Self-citationKim, Y. S., Choi, D. H., Block, M. L., Lorenzl, S., Yang, L., Kim, Y. J., Sugama, S., Cho, B. P., Hwang, O., Browne, S. E., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-5865com · Cited by 199
Self-citationCOX‐2 and Neurodegeneration in Parkinson's Disease
TEISMANN, P., VILA, M., CHOI, D. ‐., TIEU, K., WU, D. C., JACKSON‐LEWIS, V., & PRZEDBORSKI, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07482.x · Cited by 178
Carvey, P. M. (2003) · Frontiers in Bioscience · doi:10.2741/1158 · Cited by 161
Ling, Z., Zhu, Y., Tong, C. W., Snyder, J. A., Lipton, J. W., & Carvey, P. M. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.010 · Cited by 160
Feng, Z.-H., Wang, T.-G., Li, D.-D., Fung, P., Wilson, B. C., Liu, B., Ali, S. F., Langenbach, R., & Hong, J.-S. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00704-8 · Cited by 160
Self-citationThe Role of Microglia in Paraquat-Induced Dopaminergic Neurotoxicity
Wu, X.-F., Block, M. L., Zhang, W., Qin, L., Wilson, B., Zhang, W.-Q., Veronesi, B., & Hong, J.-S. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.654 · Cited by 158
Self-citationGao, H., Liu, B., Zhang, W., & Hong, J. (2003) · The FASEB Journal · doi:10.1096/fj.03-0203fje · Cited by 150
Self-citationMicroglia induce neural cell death via a proximity-dependent mechanism involving nitric oxide
Gibbons, H. M., & Dragunow, M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.02.032 · Cited by 147
Gwinn, K. A. (2002) · Movement Disorders · doi:10.1002/mds.10173 · Cited by 139
A proposed dual role of neuromelanin in the pathogenesis of Parkinson’s disease
Zecca, L., Zucca, F. A., Albertini, A., Rizzio, E., & Fariello, R. G. (2006) · Neurology · doi:10.1212/wnl.67.7_suppl_2.s8 · Cited by 138
Hudnell, H. K. (1999) · PubMed · Cited by 125
Barbeau, A., Dallaire, L., Buu, N. T., Poirier, J., & Rucinska, E. J. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90185-7 · Cited by 119
Iregren, A. (1999) · PubMed · Cited by 118
MPP + ‐induced COX‐2 activation and subsequent dopaminergic neurodegeneration
Wang, T., Pei, Z., Zhang, W., Liu, B., Langenbach, R. I., Lee, C., Wilson, B. C., Reece, J. M., Miller, D. S., & Hong, J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2457fje · Cited by 114
Self-citationParkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis
Pradhan, S., Pandey, N., Shashank, S., Gupta, R. K., & Mathur, A. (1999) · Neurology · doi:10.1212/wnl.53.8.1781 · Cited by 108
Block, M. L., Li, G., Qin, L., Wu, X., Pei, Z., Wang, T., Wilson, B. C., Yang, J. H., & Hong, J. (2006) · The FASEB Journal · doi:10.1096/fj.05-4553com · Cited by 93
Self-citationMicroglial Activation Induced by Neurodegeneration
Zhou, Y. F., Wang, Y., Kovacs, M., Jin, J., & Zhang, J. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500114-mcp200 · Cited by 80
Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition
Miwa, H., Kubo, T., Suzuki, A., Nishi, K., & Kondo, T. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.01.024 · Cited by 76
Chang, R. C. C., Hudson, P., Wilson, B., Haddon, L., & Hong, J.-S. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02255-6 · Cited by 68
Effects of Enhanced Striatal Dopamine Turnover In Vivo on Glutathione Oxidation
Loeffler, D. A., DeMaggio, A. J., Juneau, P. L., Havaich, M. K., & LeWitt, P. A. (1994) · Clinical Neuropharmacology · doi:10.1097/00002826-199408000-00009 · Cited by 61
Response of patients with postencephalitic Parkinsonism to levodopa
Duvoisin, R. C., Lobo-Antunes, J., & Yahr, M. D. (1972) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.35.4.487 · Cited by 46
Parkinsonism Before and Since the Epidemic of Encephalitis Lethargica
Duvoisin, R. C., Yahr, M. D., SCHWEITZER, M. D., & Merritt, H. H. (1963) · Archives of Neurology · doi:10.1001/archneur.1963.00460090038003 · Cited by 44
Huh, Y., Jung, J. W., Park, C., Ryu, J. R., Shin, C. Y., Kim, W.-K., & Ryu, J. H. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00743-2 · Cited by 40
Wang, T., Zhang, W., Pei, Z., Block, M. L., Wilson, B. C., Reece, J. M., Miller, D. S., & Hong, J. (2006) · The FASEB Journal · doi:10.1096/fj.05-5053com · Cited by 36
Self-citationPesticides and Parkinson’s Disease
Sherer, T., Betarbet, R. S., & Greenamyre, J. T. (2001) · The Scientific World JOURNAL · doi:10.1100/tsw.2001.35 · Cited by 21
Cited by
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Microglial Activation and Chronic Neurodegeneration
Lull, M. E., & Block, M. L. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.014 · Cited by 1,047
“Recently, we used an in vitro approach to separate neuron injury factors from the cellular actors of reactive microgliosis in an attempt to begin to discover molecular signals (soluble neuron injury factors) responsible for chronic and toxic microglial activation.166 We found that when injury with the DA neurotoxin MP…”
BackgroundInfluentialSelf-citationMicroglia-mediated neuroinflammation in neurodegenerative diseases
Subhramanyam, C. S., Wang, C., Hu, Q., & Dheen, S. T. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.004 · Cited by 870
Role of Microglia in Neurotrauma
Loane, D. J., & Byrnes, K. R. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.002 · Cited by 657
Interaction of Microglia and Astrocytes in the Neurovascular Unit
Liu, L.-R., Liu, J.-C., Bao, J.-S., Bai, Q.-Q., & Wang, G.-Q. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01024 · Cited by 589
Metadata
- Authors
- Block, M. L., & Hong, J.-S.
- Venue
- Biochemical Society Transactions
- Publisher
- Portland Press Ltd.
- Published
- 2007-10-25
- Volume
- 35
- Issue
- 5
- Pages
- 1127-1132
- ISSN
- 0300-5127 (ISSN-L)
- 1470-8752
- OpenAlex
- W2003757791
- Cited by
- 322
- References
- 61
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.